Synonyms: FX 909 | FX909
Compound class:
Synthetic organic
Comment: FX-909 is a first-in-class oral, covalent inverse agonist of the peroxisome proliferator activated receptor gamma (PPARG) nuclear hormone receptor [1]. It was developed for anti-tumour potential. The chemical structure was disclosed during the 'First Disclosures of New Drug Candidates' session at the April 2023 (Orlando) meeting of the AACR.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
3-(5,7-difluoro-4-oxo-1,4-dihydroquinolin-2-yl)-4-methanesulfonylbenzonitrile |
Synonyms ![]() |
FX 909 | FX909 |
Database Links ![]() |
|
GtoPdb PubChem SID | 479821416 |
PubChem CID | 167993670 |
Search Google for chemical match using the InChIKey | RBUBBZVQPHSZEZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | RBUBBZVQPHSZEZ |
UniChem Compound Search for chemical match using the InChIKey | RBUBBZVQPHSZEZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | RBUBBZVQPHSZEZ-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
FX-909 (links to external site)
Cat. No. HY-153344 |